Skip to main content
Medicure Inc logo

Medicure Inc — Investor Relations & Filings

Ticker · MPH ISIN · CA58469E4085 LEI · 9845007T999BF377B627 TSXV Manufacturing
Open in API
Filings indexed 293 across all filing types
Latest filing 2020-10-21 Audit Report / Informat…
Country CA Canada
Listing TSXV MPH

About Medicure Inc

https://www.medicure.com/

Medicure Inc. is a value-based pharmaceutical company specializing in the research, clinical development, and commercialization of human therapeutics. The company is primarily focused on developing and commercializing innovative and affordable medicines within the cardiovascular therapeutic area. Medicure's core mission is to serve patients by delivering safe and efficacious life-changing medicines, with a strategic focus on the U.S. market. It aims to offer a growing portfolio of products and services, ensuring patient access to necessary care.

Recent filings

Filing Released Lang Actions
Letter from successor auditor.pdf
Audit Report / Information Classification · 95% confidence The document is a letter from Ernst & Young LLP addressed to multiple Canadian securities commissions, confirming their agreement with a previously submitted Change of Auditor Notice for Medicure Inc. The letter references National Instrument 51-102 (Part 4.11), which relates to auditor changes. The document is short (959 characters) and serves as a confirmation or attestation rather than containing financial data or audit results. It does not present a full audit report or annual report but is related to audit information. According to the rules, standalone audit reports or related confirmations fall under Audit Report / Information (AR). FY 2020
2020-10-21 English
Letter from former auditor.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from PricewaterhouseCoopers LLP addressed to multiple Canadian securities commissions. It references a 'change of auditor notice' dated October 16, 2020, and confirms agreement with the statements made in that notice. The document is short (1235 characters) and serves as an attestation or confirmation related to an auditor change notice. It does not contain financial statements or detailed audit results itself, but rather supports a regulatory filing. According to the rules, such officer certifications or confirmations related to filings should be classified as Regulatory Filings (RNS).
2020-10-21 English
News release - English.pdf
Regulatory Filings
2020-10-05 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Material Change Report' and references compliance with National Instrument 51-102, which is a Canadian regulatory requirement for reporting material changes. It announces a material change related to clinical reports on AGGRASTAT® for COVID-19 treatment. The document includes a detailed description of the change, contact information, and disclaimers. It is not a full financial report, audit, earnings release, or management discussion. It is a regulatory announcement about a material change event, not a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-02 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Material Change Report' and references compliance with National Instrument 51-102, which is a Canadian regulatory requirement for reporting material changes. It announces the termination of a marketing and distribution agreement and provides detailed information about the change, including dates and involved parties. The document is not a financial report, earnings release, or management discussion but rather a regulatory announcement about a significant corporate event. It is not a report publication announcement since it contains substantive information about the material change itself. Therefore, the document fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2020-09-02 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that A.I.S. Resources Ltd. has signed a binding Letter of Intent (LOI) to acquire the Toolleen-Fosterville Gold Project. It details the terms of the acquisition, geological information about the project, and background on the company. There are no financial statements, quarterly or annual results, or regulatory filings presented. The content focuses on a capital transaction (acquisition) and exploration project details. This fits best under Capital/Financing Update (CAP) as it announces a significant acquisition agreement and related financing terms (payment and share issuance). The document length and content do not indicate it is a full report or regulatory filing, nor is it a simple announcement of a report publication. Therefore, the classification is CAP with high confidence.
2020-08-24 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.